""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

Ellen Tedaldi, MD

 

Ellen Tedaldi, MD

 

Professor, Medicine

Director, HIV Program

Telephone:  215-707-1800

Fax:  215-707-3644

Email: ellen.tedaldi@temple.edu

 

Department of Medicine, Section of General Internal Medicine

 

Educational Background:

 

BS, Cornell University, Ithica, NY

 

MD, SUNY Buffalo School of Medicine (Alpha Omega Alpha), Buffalo, NY

 

Residency, Hennepin County Medical Center, Minneapolis, MN

 

Chief Resident, Hennepin County Medical Center, Minneapolis, MN

 

Return to top

 

 

clinical interests:

 

  • HIV
  • Women's health

Return to top

 

 

research interests:

 

HIV clinical trials

 

Return to top

 

 

selected publications:

 

Tedaldi EM, Chen L, Markowitz N, Kelly L, Abrams D and the CPCRA Hepatitis Working Group. Effect of IL-2 on Hepatitis C Virus (HCV) levels in patients coinfected with  Human Immunodeficiency Virus (HIV) receiving HAART. Journal of Viral Hepatitis July 2005, 12(4):414-420.

 

Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among naive patients co-infected with hepatitis C (HCV) and and HIV-1 compared to patients without co-infection, J of Infection , 2005 May; Vol 50 (4):331-337.

 

Return to top

 

 

PUBMED PUBLICATIONS :


Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

24798779. Escárcega RO, Franco JJ, Mani BC, Vyas A, Tedaldi EM, Bove AA, Cardiovascular disease in patients with chronic human immunodeficiency virus infection. Int J Cardiol 175:1(1-7)2014 Jul 15

24493009. Tedaldi EM, Richardson JT, Debes R, Young B, Chmiel JS, Durham MD, Brooks JT, Buchacz K, Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out? J Int Assoc Provid AIDS Care 13:3(232-41)2014 May-Jun

23605401. Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, Brooks JT, Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med 28:10(1302-10)2013 Oct

23347705. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi E, Wood K, Holmberg SD, Brooks JT, Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients. Prev Chronic Dis 10:(E10)2013

23199190. Tedaldi EM, van den Berg-Wolf M, Richardson J, Patel P, Durham M, Hammer J, Henry K, Metzler S, Önen N, Conley L, Wood K, Brooks JT, Buchacz K, Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS 26:12(718-29)2012 Dec

23111762. Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT, Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther 18:1(65-75)2013

23051994. Santamore WP, Holloway-Owens L, Petersen S, Tedaldi EM, E-mail health message service. J Cardiovasc Nurs 27:6(467)2012 Nov-Dec

22591357. Wolak C, Bass SB, Tedaldi E, Vandenburg-Wolf M, Rohrer C, Minority HIV patients' perceptions of barriers and facilitators to participation in clinical research. Curr HIV Res 10:4(348-55)2012 Jun

21941640. Buchacz K, Armon C, Palella FJ, Baker RK, Tedaldi E, Durham MD, Brooks JT, CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009. AIDS Res Treat 2012:(869841)2012

21825931. Seamon MJ, Ginwalla R, Kulp H, Patel J, Pathak AS, Santora TA, Gaughan JP, Goldberg AJ, Tedaldi EM, HIV and hepatitis in an urban penetrating trauma population: unrecognized and untreated. J Trauma 71:2(306-10; discussion 311)2011 Aug

21817188. Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, Dore G, Puoti M, Tedaldi E, Clotet B, Kupfer B, Lundgren JD, Klein MB, Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir Ther 16:5(667-75)2011

21811144. Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT, Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS 25:15(1865-76)2011 Sep 24

21051598. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M, The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:6010(1551-7)2010 Dec 10

20838641. Aaron E, Kempf MC, Criniti S, Tedaldi E, Gracely E, Warriner A, Kumar R, Bachmann LH, Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication. PLoS One 5:9(e12617)2010 Sep 7

20829678. Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA, Virologic and immunologic response to HAART, by age and regimen class. AIDS 24:16(2469-79)2010 Oct 23

20597691. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, Holmberg SD, Brooks JT, Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 51:4(435-47)2010 Aug 15

20438378. Giordano TP, Bartsch G, Zhang Y, Tedaldi E, Absalon J, Mannheimer S, Thomas A, MacArthur RD, Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS 24:5(287-95)2010 May

20367803. Vellozzi C, Buchacz K, Baker R, Spradling PR, Richardson J, Moorman A, Tedaldi E, Durham M, Ward J, Brooks JT, Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007. J Viral Hepat 18:5(316-24)2011 May

20216301. Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, Clotet B, Lundgren JD, Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption. AIDS 24:6(857-65)2010 Mar 27

19635261. van den Berg-Wolf M, Tedaldi EM, Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients. Am J Med 122:8(e11)2009 Aug

19042203. Khalsa JH, Treisman G, McCance-Katz E, Tedaldi E, Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Subst Abus 29:3(5-16)2008

18959492. Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD, Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 47:11(1468-75)2008 Dec 1

18681195. Tedaldi EM, Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies. J Addict Dis 27:2(83-91)2008

18462073. van den Berg-Wolf M, Klibanov OM, Gaughan JP, Tedaldi EM, Ezetimibe Combined with Low-Dose Statin Effectively Lowers LDL in Protease Inhibitor Treated Patients. AIDS Patient Care STDS 22:6(483-8)2008 Jun

18373432. Fischer-Smith T, Tedaldi EM, Rappaport J, CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res Hum Retroviruses 24:3(417-21)2008 Mar

18176329. Tedaldi EM, Absalon J, Thomas AJ, Shlay JC, van den Berg-Wolf M, Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr 47:4(441-8)2008 Apr 1

17682998. Gaglio PJ, Sterling R, Daniels E, Tedaldi E, Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Clin Infect Dis 45:5(618-23)2007 Sep 1

16885779. Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD, Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 43:1(35-41)2006 Sep

16265606. Tedaldi EM, New drug targets for HIV and hepatitis C virus coinfection. Clin Infect Dis 41 Suppl 1:(S101-4)2005 Jul 1

15985013. Tedaldi EM, Chen L, Markowitz N, Kelly L, Abrams D, Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART. J Viral Hepat 12:4(414-20)2005 Jul

15845431. Visnegarwala F, Chen L, Raghavan S, Tedaldi E, Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect 50:4(331-7)2005 May

15156488. Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD, Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 38:10(1478-84)2004 May 15

14615655. Reisler RB, Han C, Burman WJ, Tedaldi EM, Neaton JD, Grade 4 events are as important as AIDS events in the era of HAART. J Acquir Immune Defic Syndr 34:4(379-86)2003 Dec 1

12746778. Tedaldi EM, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, Jenny-Avital ER, McGowan JP, Perez G, Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 36:10(1313-7)2003 May 15

12539079. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD, Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 36:3(363-7)2003 Feb 1

11828860. Tedaldi E, Willard S, Gilmore J, Holdsworth C, Dix-Lassiter S, Axelrod P, Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus. J Assoc Nurses AIDS Care 13:1(60-5)2002 Jan-Feb

11766416. Tedaldi E, Bean P, Diagnosis, evaluation, and treatment of HIV/HCV coinfection. Am Clin Lab 20:9(26-32)2001 Oct-Nov

4601516. Karetzky MS, Brandstetter RD, Meyer RC, Tedaldi EM, Acute asthma. I. A comparison of the immediate effects of six different modes of therapy. Am J Med Sci 267:4(213-24)1974 Apr

Return to top